Online citations, reference lists, and bibliographies.
← Back to Search

Imaging In Pleural Mesothelioma: A Review Of The 11th International Conference Of The International Mesothelioma Interest Group.

S. Armato, Z. Labby, J. Coolen, A. Klabatsa, M. Feigen, T. Persigehl, R. Gill
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Imaging of malignant pleural mesothelioma (MPM) is essential to the diagnosis, assessment, and monitoring of this disease. The complex morphology and growth pattern of MPM, however, create unique challenges for image acquisition and interpretation. These challenges have captured the attention of investigators around the world, some of whom presented their work at the 2012 International Conference of the International Mesothelioma Interest Group (iMig 2012) in Boston, Massachusetts, USA, September 2012. The measurement of tumor thickness on computed tomography (CT) scans is the current standard of care in the assessment of MPM tumor response to therapy; in this context, variability among observers in the measurement task and in the tumor response classification categories derived from such measurements was reported. Alternate CT-based tumor response criteria, specifically direct measurement of tumor volume change and change in lung volume as a surrogate for tumor response, were presented. Dynamic contrast-enhanced CT has a role in other settings, but investigation into its potential use for imaging mesothelioma tumor perfusion only recently has been initiated. Magnetic resonance imaging (MRI) and positron-emission tomography (PET) are important imaging modalities in MPM and complement the information provided by CT. The pointillism sign in diffusion-weighted MRI was reported as a potential parameter for the classification of pleural lesions as benign or malignant, and PET parameters that measure tumor activity and functional tumor volume were presented as indicators of patient prognosis. Also reported was the use of PET/CT in the management of patients who undergo high-dose radiation therapy. Imaging for MPM impacts everything from initial patient diagnosis to the outcomes of clinical trials; iMig 2012 captured this broad range of imaging applications as investigators exploit technology and implement multidisciplinary approaches toward the benefit of MPM patients.
This paper references
10.1259/BJR/13564625
Perfusion CT: a worthwhile enhancement?
K. Miles (2003)
10.1016/j.mric.2008.03.004
MR imaging of benign and malignant pleural disease.
R. Gill (2008)
10.1007/BF02967383
New guidelines to evaluate the response to treatment in solid tumors
P. Therasse (2000)
10.1093/ANNONC/MDH059
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.
M. Byrne (2004)
10.1016/J.IJNURSTU.2009.10.001
Statistical methods for assessing agreement between two methods of clinical measurement
J. Bland (1986)
10.1038/bjc.2011.436
Objective assessment of tumour response to therapy based on tumour growth kinetics
E. Mehrara (2011)
10.2967/jnumed.107.042333
Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
R. Francis (2007)
10.2214/AJR.09.3519
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
R. Gill (2010)
10.2214/AJR.05.0076
Variability in mesothelioma tumor response classification.
S. Armato (2006)
10.1118/1.3525836
Computerized segmentation and measurement of malignant pleural mesothelioma.
W. Sensakovic (2011)
[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)].
H. Watanabe (2009)
10.1259/BJR/18486642
Perfusion CT for the assessment of tumour vascularity: which protocol?
K. Miles (2003)
10.1016/j.acra.2010.10.009
Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication.
William F. Sensakovic (2011)
10.1097/JTO.0b013e3181dd0ef1
Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans
F. Liu (2010)
10.1148/radiol.12110872
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
J. Coolen (2012)
10.1093/annonc/mds535
Disease volumes as a marker for patient response in malignant pleural mesothelioma.
Z. Labby (2013)
10.1118/1.3537610
Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans.
Neal A. Corson (2011)
10.1016/0046-8177(89)90048-8
Shrinking pleuritis with lobar atelectasis, a morphologic variant of "round atelectasis".
M. Chung-Park (1989)
10.1097/JTO.0b013e318269fe21
Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma
Z. Labby (2012)
10.1118/1.1688211
Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.
S. Armato (2004)
10.1016/j.neuroimage.2010.09.025
A reproducible evaluation of ANTs similarity metric performance in brain image registration
B. Avants (2011)
10.2214/AJR.11.7015
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
R. Gill (2012)
10.1183/09031936.00146110
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
T. Frauenfelder (2011)
10.2214/AJR.155.5.2120965
Malignant pleural mesothelioma: CT manifestations in 50 cases.
A. Kawashima (1990)
10.1097/JTO.0b013e31828354c8
Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma
Zacariah E Labby (2013)
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR 2010;195:W125–30
RR Gill (2010)
10.1016/J.LUNGCAN.2005.12.013
Modeling of mesothelioma growth demonstrates weaknesses of current response criteria.
G. Oxnard (2006)
10.1016/s0140-6736(65)91037-8
AKUFO AND IBARAPA.
A. H. Beckett (1965)
10.5555/URI:PII:0093775481900361
Pathology of human malignant mesothelioma.
Y. Suzuki (1981)
10.3978/j.issn.2225-319X.2012.10.07
Novel radiation therapy approaches in malignant pleural mesothelioma.
A. Rimner (2012)
10.1002/ART.11393
Shrinking lung syndrome in systemic sclerosis.
C. Scirè (2003)
10.1097/00124743-200212000-00011
Shrinking lung syndrome in systemic lupus erythematosus and Sjogren's syndrome.
R. Singh (2002)



This paper is referenced by
10.1016/j.lungcan.2018.11.033
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
S. Armato (2019)
10.2214/AJR.11.7015
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
R. Gill (2012)
10.1016/j.mric.2015.01.006
Novel MR Imaging Applications for Pleural evaluation.
Ritu R Gill (2015)
10.21037/shc.2018.07.01
Advances in mesothelioma imaging and implications for surgical management
K. Blyth (2018)
10.21608/resoncol.2018.4306.1062
Four versus Six Cycles of Pemetrexed/Platinum as a First Line Treatment of Malignant Pleural Mesothelima: Results of a Randomized Phase II Study
A. Nagy (2018)
10.1007/s00408-016-9909-9
Applications of Magnetic Resonance Imaging of the Thorax in Pleural Diseases: A State-of-the-Art Review
Fernanda Miraldi Clemente Pessôa (2016)
10.1183/09031936.00207213
Multimodal management of malignant pleural mesothelioma: where are we today?
P. V. Van Schil (2014)
10.1007/978-1-4939-2374-8_3
Clinical and Radiologic Features
A. Roden (2015)
10.1016/J.RMCLC.2015.04.020
ASPECTOS DIAGNÓSTICOS Y TERAPÉUTICOS EN EL MESOTELIOMA PLEURAL MALIGNO
Pinto Rodríguez (2015)
10.1080/14656566.2016.1176145
Advances in treatment of mesothelioma
C. Maggioni (2016)
10.1016/j.crad.2019.12.001
The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.
S. Sinha (2020)
10.1016/j.lungcan.2015.08.012
Response evaluation in mesothelioma: Beyond RECIST.
Lin Cheng (2015)
10.1016/j.ejro.2019.01.006
Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor
T. Hino (2019)
10.1007/978-3-319-40618-3_37
Malignant pleural mesothelioma.
D. Ettinger (2012)
10.1007/s00270-017-1583-7
A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma
B. Welch (2017)
10.1016/j.critrevonc.2016.05.004
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
10.1016/J.EJRNM.2016.12.011
Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
Mohamed Houseni (2017)
10.1002/14651858.CD012605.pub2
Radical multimodality therapy for malignant pleural mesothelioma.
O. Abdel-Rahman (2018)
10.1016/j.lungcan.2018.01.014
Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy
S. Tsim (2018)
10.1097/MCP.0000000000000066
Role of imaging in diagnosis, staging and follow-up of lung cancer
Walter De Wever (2014)
10.1016/j.jtho.2019.08.012
Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T
R. Gill (2019)
10.1016/j.lungcan.2020.09.025
A comparison between MRI and CT in the assessment of primary tumour volume in mesothelioma.
S. Tsim (2020)
10.1007/s00261-014-0224-8
Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists
R. Vicens (2014)
10.1097/MCP.0000000000000177
MRI of pleural diseases
J. Coolen (2015)
10.23750/abm.v88i2.5558
Diagnostic imaging and workup of malignant pleural mesothelioma
Luciano Cardinale (2017)
BIBLIOGRAPHIC REVIEW July 2016 Third Consensus Conference on Malignant Pleural Mesothelioma: State-of-the-art and recommendations
(2016)
10.1007/s00259-014-2960-y
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma
E. Lopci (2014)
10.1016/j.rmcr.2013.12.004
An unusual cause of an anterior mediastinal mass
I. Hassan (2014)
Malignant pleural mesothelioma: ESMOClinical Practice Guidelines for diagnosis, treatment and follow-up†
Paul Baas (2015)
10.1097/RCT.0000000000000174
Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma
T. Frauenfelder (2015)
The pleura 2.0: Functional imaging and oncology applications
Jordi Broncano (2015)
10.1017/9781316402009.004
Multi-modality Imaging of Pleural and Peritoneal Disease
J. Cunningham (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar